A large multicenter RCT of timolol, NSBB, versus placebo performed in patients with cirrhosis and portal hypertension but without varices, showed a similar rate of development of varices in both treatment groups, with a higher rate of adverse events in the timolol group. 1 Therefore, NSBB are not recommended for the prevention of varices..